Background: The purpose of the study was to assess the effectiveness of prebiotic fructooligosaccharide (FOS) mixture and probiotic () when administered subgingivally as a supplement to scaling and root planing (SRP) in the treatment of chronic periodontitis. In addition, the N benzoyl DL arginine naphthylamide (BANA) test was used to examine the impact of probiotics on red complex organisms.

Materials And Methods: Twenty systemically healthy participants with chronic periodontitis, with at least two periodontal pockets in each quadrant exhibiting probing depth (PD) ≥5 mm and clinical attachment level (CAL) ≥3 mm, participated in this split-mouth randomized controlled research. Two randomly chosen sites were chosen for each subject: one for testing, where SRP was followed by subgingival placement of the probiotic-prebiotic cocktail, and the other for control, where SRP alone was used. Assessments were conducted from baseline to 6 months later for the plaque index (PI), gingival index (GI), PD, and CAL. BANA was used to perform microbial assessments at baseline and at 1, 3, and 6 months. At certain intervals, the probiotic's () vitality was assessed both and in the pocket.

Results: In both groups, there was a significant decrease in every clinical measure. A noteworthy enhancement was seen in the test group's PI, GI, PPD, and CAL upon intergroup comparison in contrast to the control group. When comparing groups, it was shown that the test group's BANA had significantly decreased after 3 and 6 months. While there was a significant difference and increase in vitality between the days, there was a significant difference and decrease in viability in the days that followed as compared to the day before.

Conclusion: In comparison to SRP alone, subgingival administration of a probiotic-prebiotic mixture can be advantageous in non-surgical periodontal therapy for patients with chronic periodontitis and in managing the red complex organism's recolonization over time.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11805286PMC
http://dx.doi.org/10.4103/jpbs.jpbs_1175_24DOI Listing

Publication Analysis

Top Keywords

chronic periodontitis
12
non-surgical periodontal
8
periodontal therapy
8
red complex
8
srp subgingival
8
baseline months
8
test group's
8
split-mouth study
4
study evaluate
4
evaluate adjunctive
4

Similar Publications

Proanthocyanidin B2 alleviates LPS-induced RAW264.7 cellular inflammation and oxidative stress via PI3K/Akt/NFkB pathway.

Cytotechnology

April 2025

The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, NO.688, Honggu North Road, Honggu Tan District, Nanchang City, 330038 Jiangxi Province China.

Periodontitis is a multifactorial chronic inflammatory infectious disease associated with systemic diseases. Proanthocyanidin B2 (PB2), a polyphenol, has been investigated to exhibit antioxidant, anti-inflammatory and anti-cancer pharmacological properties. PB2 has shown good efficacy in treating hepatocellular carcinoma, type 2 diabetes mellitus, and ulcerative colitis.

View Article and Find Full Text PDF

Head and neck cancers (HNCs) are often diagnosed late, leading to poor prognosis. Chronic inflammation, particularly periodontitis, has been linked to carcinogenesis, but systemic inflammatory markers remain underexplored. This study was the first to examine whether elevated C-reactive protein (CRP) can serve as a cost-effective adjunct in HNC risk assessment, alongside oral health indicators.

View Article and Find Full Text PDF

Injectable hydrogels with ROS-triggered drug release enable the co-delivery of antibacterial agent and anti-inflammatory nanoparticle for periodontitis treatment.

J Nanobiotechnology

March 2025

Oral & Maxillofacial Reconstruction and Regeneration of Luzhou Key Laboratory, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, 646000, China.

Periodontitis, a chronic inflammatory disease caused by bacteria, is characterized by localized reactive oxygen species (ROS) accumulation, leading to an inflammatory response, which in turn leads to the destruction of periodontal supporting tissues. Therefore, antibacterial, scavenging ROS, reducing the inflammatory response, regulating periodontal microenvironment, and alleviating alveolar bone resorption are effective methods to treat periodontitis. In this study, we developed a ROS-responsive injectable hydrogel by modifying hyaluronic acid with 3-amino phenylboronic acid (PBA) and reacting it with poly(vinyl alcohol) (PVA) to form a borate bond.

View Article and Find Full Text PDF

The Oral-Systemic Link: Controversies and Policy Implications.

J Oral Pathol Med

March 2025

Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Carlton, Victoria, Australia.

Oral health has never been more central to the political agenda than it is today, particularly in the context of broader health policy. However, there are important caveats to consider when assessing the oral-systemic nexus.

View Article and Find Full Text PDF

There is a plethora of evidence that suggests infection may either directly or indirectly trigger chronic inflammatory processes which may then act as a risk factor for diabetes mellitus and atherosclerosis. Inflammatory periodontal disease like periodontitis, is among the most prevalent oral infectious disease. It affects the tissues that support the teeth and has reportedly been linked to systemic conditions like diabetes mellitus and atherosclerosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!